Evidence map›Paper›PMID 35517883›Full record

ArticleAdvanced pharmaceutical bulletin2022

High Sensitivity Troponin T as Complementary Modality for Determining Doxorubicin Regimen Cardiotoxicity in Non-Hodgkin Lymphoma Patients.

Ami Ashariati Prayogo, Satriyo Dwi Suryantoro, Merlyna Savitri, Winona May Hendrata, Andi Yasmin Wijaya, Budi Susetyo Pikir

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced pharmaceutical bulletin, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Observational
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ami Ashariati PrayogoDivision of Hematology-Oncology, Department of Internal Medicine, Dr. Soetomo Teaching Hospital, Surabaya, East Java, Indonesia.ORCID https://orcid.org/0000-0003-0508-4496
Satriyo Dwi SuryantoroDepartment of Internal Medicine, Airlangga University Hospital, Surabaya, East Java, Indonesia.
Merlyna SavitriDivision of Hematology-Oncology, Department of Internal Medicine, Dr. Soetomo Teaching Hospital, Surabaya, East Java, Indonesia.
Winona May HendrataFaculty of Medicine, Airlangga University, Surabaya, East Java, Indonesia.ORCID https://orcid.org/0000-0003-3867-7773
Andi Yasmin WijayaFaculty of Medicine, Airlangga University, Surabaya, East Java, Indonesia.ORCID https://orcid.org/0000-0002-6463-6265
Budi Susetyo PikirFaculty of Medicine, Airlangga University, Surabaya, East Java, Indonesia.
Airlangga University · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CancerCardiotoxicityDoxorubicinLeft ventricular functionNon-Hodgkin lymphomaTroponin T

Identifiers

PMID35517883
PMCPMC9012930
OpenAlexW3096532052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.